Stay updated on XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial
Sign up to get notified when there's something new on the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page.

Latest updates to the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page
- Check6 days agoChange DetectedRecruitment status is updated to indicate enrollment is closed, and new user-guidance sections were added to help users understand the study record and how to join. A label formatting change for Intervention/Treatment and a revision tag update were also applied.SummaryDifference0.5%

- Check13 days agoChange DetectedThe page revision in the footer was updated from v3.5.4 to v3.5.5, indicating a newer version of the page. This reflects a metadata update rather than a change to the visible content.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRemoved the Related Topics entries (including Prostate cancer and MedlinePlus Genetics) from the study page. This reduces the related resources displayed alongside the study details, affecting navigational context for users exploring related topics.SummaryDifference0.2%

- Check34 days agoChange DetectedThe page's related topics area gained Prostate cancer and a MedlinePlus Genetics link, and the site revision updated from v3.5.3 to v3.5.4.SummaryDifference0.2%

- Check56 days agoChange DetectedA minor ClinicalTrials.gov interface/version update is reflected on the page (revision v3.5.2 replaced by v3.5.3). This does not change any of the study details presented.SummaryDifference0.1%

- Check63 days agoChange DetectedA new page revision, v3.5.2, was added, replacing the previous v3.5.0.SummaryDifference0.1%

Stay in the know with updates to XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page.